The Programme is a 6-12 month scale up programme (depending on stage), connecting you with academia, industry and the healthcare sectors to create a clear innovation pathway.
We want every company within precision medicine to apply.
To gain the full benefit from this programme, it’s advised that companies:
- Work in the area of Precision Medicine*
- Be early- to mid-stage medical device, diagnostic, or digital health companies
- Not yet closed a Series B
- Be data-driven
- Be able to demonstrate their route to market with a time-frame of 12 – 18 months
- Have already received seed/grant funding
- Show team credibility (at least 3 members with complimentary and relevant expertise)
- Have Data Scientist involvement
- Use of AI
*Precision (aka personalised) medicine is an approach that will allow doctors and researchers to predict more accurately which treatment and prevention strategies for a particular disease will work in which groups of people. An example is colon cancers that have a normally functioning version of a surface protein called KRAS are likely to respond to certain anti-EGFR antibody therapies; those in which the protein is absent or non-functional are not.
6 Month scale up programme
Together with our strategic partners and mentors, participants benefit from dedicated workshops, 1-1 expert advice, networking and investment connections to scale.
Academic and Industry
We connect you to either academic or industry experts to support you in building tech that can be scaled across healthcare.
Experts that understand the pain points of gaining regulatory approval ensuring the process is as smooth as possible.
Testbeds and Trial Opportunities
Specialised network to foster collaboration from patient groups, health trusts and academia to drive your innovation forward.
Specialised Investor Introductions
Unique and specialised network of funders that are actively looking to invest.
Bringing a mix of investors from industry experts, sector experts to founders that have been through the journey.
Key Decision Makers
A curated contact network of key decision makers from active clinicians, academics and industry professionals.
Oct – Dec Applications open Oct – Dec. Application will be reviewed through Dec- Jan by our multi organisational panel including UCL, Capital Enterprise, UCLPartners and more. This is to identify companies that will benefit the most from the programme, have great patient impact and move precision medicine innovations forward.
Feb – December The programme consists of a mixture of workshops, expert 1-1s, industry and academic tech support, clinical trial collaboration access, health economics support, NHS networking opportunities (currently virtual due to COVID-19).
October At the end of the programme you have the chance to present to industry and investors to increase traction and pique investors interest for your next round of investment.
Post Programme Being part of the programme alumni, companies will be able to access industry events, carrying on participation for clinical trials and R&D with our partners, focused networking events and other scale up opportunities.